Results 21 to 30 of about 11,297 (212)

Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review

open access: yesHematology, 2021
Objectives To determine the rate of RhD-alloimmunization in injured RhD-negative patients in the age range of childbearing potential who were transfused with at least one unit of RhD-positive red blood cells (RBC) or low titer group O whole blood (LTOWB).
M. Yazer   +4 more
semanticscholar   +1 more source

How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.

open access: yesHematology. American Society of Hematology. Education Program, 2021
Erythrocyte alloimmunization is a major barrier to transfusion in sickle cell disease (SCD) because it can lead to transfusion deadlock and the development of life-threatening hemolytic transfusion reactions (HTRs).
F. Pirenne, A. Floch, A. Habibi
semanticscholar   +1 more source

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions.

open access: yesBlood Advances, 2021
Chronically transfused patients with thalassemia are at risk for red cell alloimmunization. No studies have specifically examined alloimmunization after implementation of prophylactic Rh (D, C, E) and K matched red cells in a racially diverse population ...
Sarah J Waldis   +7 more
semanticscholar   +1 more source

Crossmatch: Alloimmunization versus unspecific agglutination reactions?

open access: yes, 2023
Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 8-9, January/February 2023.
Urs Giger
wiley   +1 more source

Impact of hyperlipidemia on alloimmunity [PDF]

open access: yesCurrent Opinion in Organ Transplantation, 2017
Hyperlipidemia is a comorbidity affecting a significant number of transplant patients despite treatment with cholesterol lowering drugs. Recently, it has been shown that hyperlipidemia can significantly alter T-cell responses to cardiac allografts in mice, and graft rejection is accelerated in dyslipidemic mice.
Jin Yuan, John Iacomini, Jessamyn Bagley
openaire   +2 more sources

Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. [PDF]

open access: yes, 1989
Intraoperative blood requirements were analyzed in patients undergoing primary orthotopic liver transplantation and divided into two groups on the basis of panel reactive antibody of pretransplant serum measured by lymphocytotoxicity testing.
Duquesnoy, RJ   +5 more
core   +1 more source

The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran

open access: yesMolecular Genetics & Genomic Medicine, 2021
The alloimmunization following blood transfusion can be life‐threatening. The Rh alloantibodies are one of the most common causes contributing to alloimmunization.
Mohammad Ali Jalali Far   +4 more
semanticscholar   +1 more source

Micromanaging alloimmunity [PDF]

open access: yesJournal of Clinical Investigation, 2016
Increasing evidence indicates that microbes have a large influence on immune function. Previous studies have linked pathogenic microorganisms with decreased allograft tolerance and subsequent rejection. In this issue of the JCI, Lei and colleagues demonstrate that commensal organisms also influence the host response to allograft transplantation.
openaire   +2 more sources

Leucoreduction of blood components. an effective way to increase blood safety? [PDF]

open access: yes, 2015
Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens
Bianchi, Maria   +6 more
core   +1 more source

Transfusional approach in multi-ethnic Sickle Cell patients: real-world practice data from a Multicenter survey in Italy [PDF]

open access: yes, 2022
Sickle cell disease (SCD) is a worldwide distributed hereditary red cell disorder characterized by recurrent acute vaso-occlusive crises (VOCs and anemia).
Allò, M   +47 more
core   +2 more sources

Home - About - Disclaimer - Privacy